Please login to the form below

Not currently logged in
Email:
Password:

Valeant adds Robert Hale to board of directors

And Jeffrey Ubben resigns from the board
Valeant Robert Hale

Valeant has added Robert Hale, a partner at ValueAct Capital, to its board of directors.

Hale will be the fourth partner of ValueAct Capital, which holds approximately 4% of Valeant's outstanding stock, to serve on the Valeant board.

ValueAct Capital has been a shareholder in Valeant since 2006 and as a partner there Hale has worked closely with the board and management team since January 2011.

He said: “It's an exciting time for Valeant as the company positions itself for long-term growth and leadership in the pharmaceuticals and medical products industry.”

Meanwhile, Jeffrey Ubben, CEO and CIO of ValueAct Capital has resigned from the board.

He said: “I have had a wonderful experience serving as director of Valeant. While I no longer serve as a director, I look forward to working with Mike Pearson and the Valeant team as an interested shareholder on an on-going basis.”

Michael Pearson, chairman and CEO of Valeant, said: “We are delighted that we will continue to have board representation from ValueAct Capital.

“We have gotten to know Rob well over the past five years and are glad that he now serves as a director. Rob's strategic and financial expertise will add a valuable perspective to our board.”

Hale, prior to his current position, was principal of The Parthenon Group working at both their Boston and Mumbai offices.

27th August 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics